Markets:

Overview

News

Currencies

International

Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

80.08 -2.92 (-3.52%)

Streaming Delayed Price Updated: 3:09 PM EDT, Jun 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ANI Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Dow, SPX Fall From Record Intraday Highs ↗

November 01, 2021

Stocks are mixed at midday, with the Dow Jones Industrial Average reversing some of this morning's gains after briefly toppling the 36,000 level for the first time ever.

Via Talk Markets

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 01, 2021

Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's regular session. As of 12:30 EST, this security is trading at a volume...

Via Benzinga

Here's Why Ani Pharmaceuticals Stock Is Rocketing Higher Today ↗

November 01, 2021

The company reported positive third-quarter earnings, and the FDA granted approval for its generic version of Acthar Gel.

Via The Motley Fool

Topics Bankruptcy Lawsuit

Mid-Day Market Update: Dow Rises 50 Points; ANI Pharmaceuticals Shares Jump ↗

November 01, 2021

Midway through trading Monday, the Dow traded up 0.14% to 35,871.27 while the NASDAQ rose 0.23% to 15,534.49. The S&P also fell, dropping 0.03% to 4,603.98. The U.S. has the...

Via Benzinga

Topics Stocks

Ani Pharma Rockets After Winning FDA Approval To Revive Old Merck Drug ↗

November 01, 2021

Cortophin Gel gained approval to treat several autoimmune conditions.

Via Investor's Business Daily

40 Stocks Moving In Monday's Mid-Day Session ↗

November 01, 2021

Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares jumped 250% to $8.91 on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the...

Via Benzinga

ANI Pharmaceuticals's Return On Capital Employed Overview ↗

November 01, 2021

According to Benzinga Pro data, during Q3, ANI Pharmaceuticals (NASDAQ:ANIP) posted sales of $52.06 million. Earnings were up 77.1%, but ANI Pharmaceuticals still reported an...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; PG&E Earnings Miss views ↗

November 01, 2021

Following the market opening Monday, the Dow traded up 0.08% to 35,846.72 while the NASDAQ rose 0.18% to 15,527.04. The S&P also fell, dropping 0.07% to 4,602.32. The U.S. has...

Via Benzinga

Topics Earnings Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 01, 2021

Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's pre-market session. The company's market cap stands at $27.1...

Via Benzinga

ANI Pharmaceuticals Reports Third Quarter 2021 Results

November 01, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces FDA Approval of Purified Cortrophin™ Gel for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis and Nephrotic Syndrome

November 01, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Discuss Third Quarter 2021 Financial Results on November 1, 2021

October 29, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

Earnings Scheduled For November 1, 2021 ↗

November 01, 2021

Companies Reporting Before The Bell • ANI Pharmaceuticals (NASDAQ:ANIP) is expected to report earnings for its third quarter. • Kiniksa Pharmaceuticals (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs ↗

October 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Gilead, Merck to Study Trodelvy-Keytruda Combo For Breast Cancer Gilead, Inc...

Via Benzinga

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates ↗

October 01, 2021

Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned. Four new...

Via Benzinga

ANI Pharmaceuticals to Present at Cantor Virtual Global Healthcare Conference 2021

September 20, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces Launch of Nebivolol Tablets

September 17, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

Looking Into ANI Pharmaceuticals's Return On Capital Employed ↗

September 09, 2021

Benzinga Pro data, ANI Pharmaceuticals (NASDAQ:ANIP) reported Q2 sales of $48.62 million. Earnings fell to a loss of $15.55 million, resulting in a 610.77% decrease from last...

Via Benzinga

ANI Pharma's Purified Cortrophin Gel Application Under FDA Review ↗

August 31, 2021

The FDA has accepted ANI Pharmaceuticals Inc's (NASDAQ: ANIP) supplemental marketing application for Purified Cortrophin Gel. The application seeks approval...

Via Benzinga

ANI Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, and Nephrotic Syndrome

August 31, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals, inc (ANIP) Q2 2021 Earnings Call Transcript ↗

August 06, 2021

ANIP earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Recap: ANI Pharmaceuticals Q2 Earnings ↗

August 06, 2021

Shares of ANI Pharmaceuticals (NASDAQ:ANIP) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share fell 2.90% year over year to $0.67,...

Via Benzinga

ANI Pharmaceuticals Reports Second Quarter 2021 Results

August 06, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗

August 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

Earnings Scheduled For August 6, 2021 ↗

August 06, 2021

Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million....

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

ANI Pharmaceuticals to Discuss Second Quarter 2021 Financial Results on August 6, 2021

July 22, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces Refiling of Cortrophin sNDA with FDA

July 06, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021

June 15, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.